Study to Determine the Effects Treatment With Amlexanox 0.5% Oral Rinse Solution on Oral Mucositis Associated With Radiation Therapy for Cancer of the Head and Neck Region
Clinical trial NCT01083875 · COMPLETED
Trial details
- NCT number
- NCT01083875
- Sponsor
- Access Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-02-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.